PEAK6 Group’s Surmodics SRDX Stock Holding History

PEAK6 Group’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-460	Closed	-$14K	–	4752
2017 Q3	$14K	Sell	460 -158	-26%	-$4.3K	﹤0.01%	4206
2017 Q2	$17K	Buy	+618	New	+$14.9K	﹤0.01%	4329
2013 Q4	–	Sell	-3,736	Closed	-$88.1K	–	5410
2013 Q3	$44K	Buy	+3,736	New	+$80.1K	﹤0.01%	4584

Other funds holding SRDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Group's SRDX Position: Q4 2017 in Review

PEAK6 Group sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 460 shares — an estimated $14K sold.

PEAK6 Group first reported a position in SRDX in Q3 2013 and held it in 3 quarters. The position peaked at $44K in Q3 2013. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

PEAK6 Group reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 460 Surmodics shares in Q4 2017, an estimated $14K.
PEAK6 Group first reported a position in Surmodics in Q3 2013 and held it in 3 quarters.
PEAK6 Group's Surmodics position peaked at $44K in Q3 2013.
115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.